Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Prognostic impact of ventilation-perfusion defects and pulmonary diffusing capacity after single lung transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Severe Unilateral Lung Parenchymal Opacities: A Unique Presentation of Granulomatosis with Polyangiitis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS) are two distinct phenotypes of chronic lung allograft dysfunction (CLAD) in lung transplant (LTx) recipients. Contrary to BOS, RAS can radiologically present with a pleuroparenchymal fibroelastosis (PPFE) pattern. This study investigates lung ultrasound (LUS) to identify potential surrogate markers of PPFE in order to distinguish CLAD phenotype RAS from BOS.

METHODS: A prospective cohort study performed at a National Lung Transplantation Center during June 2016 to December 2017. Patients were examined with LUS and high-resolution computed tomography of the thorax (HRCT).

RESULTS: Twenty-five CLAD patients (72% males, median age of 54 years) were included, corresponding to 19/6 BOS/RAS patients. LUS-identified pleural thickening was more pronounced in RAS vs. BOS patients (5.6 vs. 2.9 mm) compatible with PPFE on HRCT. LUS-identified pleural thickening as an indicator of PPFE in RAS patients' upper lobes showed a sensitivity of 100% (95% CI; 54-100%), specificity of 100% (95% CI; 82-100%), PPV of 100% (95% CI; 54-100%), and NPV of 100% (95% CI; 82-100%).

CONCLUSION: Apical pleural thickening detected by LUS and compatible with PPFE on HRCT separates RAS from BOS in patients with CLAD. We propose LUS as a supplementary tool for initial CLAD phenotyping.

Original languageEnglish
JournalJournal of Clinical Medicine
Volume10
Issue number5
ISSN2077-0383
DOIs
Publication statusPublished - 5 Mar 2021

ID: 64730996